December 4, 2019 - 4:00 PM
December 7, 2019 - 12:05 PM
Who Should Attend
Attendance is limited to 400 HIV physicians, nurse practitioners, and physician assistants in Ryan White HIV/AIDS Program (RWHAP)-funded clinics and programs. A limited number of spots are reserved for RNs and PharmDs who are the primary clinical decision makers in their RWHAP-funded clinics or programs.
Attendance to this 2019 CLINICAL CONFERENCE is limited, and all attendees must be approved. Please do not book hotel accommodations or make travel arrangements prior to receiving notification that your application to attend has been approved.
** If you do not receive an application status notification within 2 business days of submitting your application, please check your spam folder. Otherwise, please email firstname.lastname@example.org.
2019 CLINICAL CONFERENCE Description
The 2019 CLINICAL CONFERENCE will provide state-of-the-art updates on research, care, and treatment issues in the medical management of HIV infection for experienced HIV clinical decision makers.
The 2019 CLINICAL CONFERENCE is planned with and supported by the HIV/AIDS Bureau, Health Resources and Services Administration of the US Department of Health and Human Services (HRSA) and is sponsored and organized by the International Antiviral Society–USA (IAS–USA). This conference is coordinated through the RWHAP AIDS Education and Training Centers (AETC) clinician training network. A mix of lectures, case-based interactive presentations, and small-group workshop breakout sessions will be held during the three days of the 2019 CLINICAL CONFERENCE.
The educational objectives for the 2019 CLINICAL CONFERENCE are designed and developed based on the identified needs and knowledge gaps of the attendees.
On completion of the 2019 CLINICAL CONFERENCE, participants will be able to:
- Describe the new aspects to the Ryan White HIV/AIDS Program
- Apply current data on HIV management that includes antiretroviral treatment strategies for medical care of people with established HIV infection and the consideration of special clinical circumstances, such as pregnancy
- Describe current data on investigational new drugs and approaches
- Determine which patients might benefit from prevention intervention strategies, including the use of preexposure prophylaxis (PrEP), and initiate and monitor uninfected patients at risk for HIV infection
- Describe the current epidemiology, clinical presentations, and management of the most common sexually transmitted infections (STIs) in patients with HIV infection
- Detect and manage common comorbidities occurring in the aging population of persons with HIV infection, including renal disease and those in need of transplant, cardiovascular disease, and neurocognitive disorders
- Identify individuals with chronic opioid dependency and develop treatment strategies for the management of these patients with opioid substitution therapy
- Identify best practices for ending the HIV epidemic
Continuing Education Credits
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The IAS–USA designates this live activity for a maximum of 17.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Points
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 17.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
American Academy of Family Physicians Credits
This activity is eligible for AAFP credit; see the final CNE activity announcement for details.
This activity is eligible for ANCC credit; see the final CNE activity announcement for details.
This activity is eligible for ACPE credit; see the final CPE activity announcement for details.
This conference is funded by Health Resources and Services Administration (HRSA) of the US Department of Health and Human Services (HHS) under grant number U1OHA28686 (AIDS Education and Training Center National Coordinating Resource Center) awarded to the François-Xavier Bagnoud Center from the Rutgers University School of Nursing with a sub award to International Antiviral Society–USA (IAS–USA) to sponsor this CME activity. Attendees are responsible for their transportation expenses to and from New Orleans, hotel stay costs, meals, and all other expenses. Please check with your project officer about expenses that are covered by your RWHAP award.